The global cat vaccine market size is expected to reach USD 2.5 billion by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030. Rising pet ownership, emerging diseases in cats, and rising disposable income is expected to increase the market value for cat vaccines. Furthermore, pharmaceutical industry investments are also expected to boost market growth. ![Global Cat Vaccine Market]( "Global Cat Vaccine Market")
The rising market trend is due to the growing awareness among pet owners about the necessity of cat vaccines, promoting preventive healthcare, and ensuring the well-being of their feline companions. Pet owners now prioritize products that match their pets' dietary needs and personal values, turning to online pet brands for convenient access to premium and nutritious pet items.
This product will be delivered within 1-3 business days.
The rising market trend is due to the growing awareness among pet owners about the necessity of cat vaccines, promoting preventive healthcare, and ensuring the well-being of their feline companions. Pet owners now prioritize products that match their pets' dietary needs and personal values, turning to online pet brands for convenient access to premium and nutritious pet items.
Cat Vaccine Market Report Highlights
- Based on vaccine type, the modified/attenuated live segment dominated the market with the largest revenue share of 50.1% in 2023. The demonstrated efficacy of modified/attenuated live vaccines against feline panleukopenia and herpesvirus, has boosted confidence in both pet owners and veterinarians.
- Based on disease type, the feline respiratory diseases (FRDs) segment held the largest share of 32.4% in 2023 owing to the increasing prevalence of FRDs, eventually driving market growth.
- The feline leukemia segment is anticipated to witness the fastest CAGR of 9.8% over the forecast period.
- Based on route of administration, the injectables segment held the largest market share, with 77.4% in 2023. Continuous research and development in vaccine technology are propelling the injectables segment in the market.
- Based on duration of immunity, the 1-year segment held the largest market share of 50.1% in 2023 and the diligent and evidence-based practices of veterinary organizations such as the American Association of Feline Practitioners (AAFP) guide the development of safe and effective vaccines.
- Based on component, the combined vaccine segment held the largest market share, with 64.0% in 2023, and is expected to grow at the fastest CAGR of 9.5% over the forecast period.
- In 2023, North America dominated the market with a revenue share of 38.1% owing to the strict regulations overseeing animal vaccines and upholding high-quality feline healthcare standards.
- Some of the major companies include Virbac; C.H. Boehringer Sohn AG & Co. KG.; Elanco; Zoetis; Merck & Co.; Bioveta, a.s.; Indian Immunologicals Ltd.; among others.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Vaccine type
1.2.2. Disease type
1.2.3. Route of administration
1.2.4. Duration of immunity
1.2.5. Component
1.2.6. Region
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Vaccine type
1.2.2. Disease type
1.2.3. Route of administration
1.2.4. Duration of immunity
1.2.5. Component
1.2.6. Region
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Vaccine type outlook
2.2.2. Disease type outlook
2.2.3. Route of administration outlook
2.2.4. Duration of immunity outlook
2.2.5. Component outlook
2.2.6. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Vaccine type outlook
2.2.2. Disease type outlook
2.2.3. Route of administration outlook
2.2.4. Duration of immunity outlook
2.2.5. Component outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Cat Vaccines Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising pet ownership
3.2.1.2. Emerging diseases in cats
3.2.1.3. Rising disposable income
3.2.1.4. Pharmaceutical industry investment
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory policies and regulations
3.2.2.2. High cost of Vaccines
3.3. Cat Vaccines Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising pet ownership
3.2.1.2. Emerging diseases in cats
3.2.1.3. Rising disposable income
3.2.1.4. Pharmaceutical industry investment
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory policies and regulations
3.2.2.2. High cost of Vaccines
3.3. Cat Vaccines Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Cat Vaccines Market: Vaccine Type Estimates & Trend Analysis
4.1. Vaccine Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Cat Vaccines Market by Vaccine Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Modified/attenuated (live)
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Inactivated (killed)
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Others
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Segment Dashboard
4.3. Global Cat Vaccines Market by Vaccine Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Modified/attenuated (live)
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Inactivated (killed)
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Others
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Cat Vaccines Market: Disease Type Estimates & Trend Analysis
5.1. Disease Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Cat Vaccines Market by Disease Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Feline leukemia
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Feline panleukopenia (Feline distemper)
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Feline respiratory diseases
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Feline rabies
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Other diseases
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.2. Segment Dashboard
5.3. Global Cat Vaccines Market by Disease Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Feline leukemia
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Feline panleukopenia (Feline distemper)
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Feline respiratory diseases
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Feline rabies
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Other diseases
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Cat Vaccines Market: Route of Administration Estimates & Trend Analysis
6.1. Route of Administration Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Cat Vaccines Market by Route of Administration Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Injectables
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Intranasal
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Oral
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.2. Segment Dashboard
6.3. Global Cat Vaccines Market by Route of Administration Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Injectables
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Intranasal
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Oral
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Cat Vaccines Market: Duration of Immunity Estimates & Trend Analysis
7.1. Duration of Immunity Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Cat Vaccines Market by Duration of Immunity Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. 1 Year
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. 3 Years
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Others
7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.2. Segment Dashboard
7.3. Global Cat Vaccines Market by Duration of Immunity Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. 1 Year
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. 3 Years
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Others
7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Cat Vaccines Market: Component Estimates & Trend Analysis
8.1. Component Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Global Cat Vaccines Market by Component Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
8.4.1. Combined vaccine
8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
8.4.2. Mono vaccine
8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.2. Segment Dashboard
8.3. Global Cat Vaccines Market by Component Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
8.4.1. Combined vaccine
8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
8.4.2. Mono vaccine
8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Cat Vaccines Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/ reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/ reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/ reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/ reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/ reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/ reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/ reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/ reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. Mexico
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/ reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework/ reimbursement structure
9.8.3.3. Competitive scenario
9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/ reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/ reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/ reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/ reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/ reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/ reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/ reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/ reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/ reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/ reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/ reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/ reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. Mexico
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/ reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework/ reimbursement structure
9.8.3.3. Competitive scenario
9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/ reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/ reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/ reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/ reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.4. Company Profiles
10.4.1. Virbac
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. C.H. Boehringer Sohn AG & Co. KG.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Elanco
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Zoetis
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Merck & Co.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Bioveta, a.s.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Indian Immunologicals Ltd
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.4. Company Profiles
10.4.1. Virbac
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. C.H. Boehringer Sohn AG & Co. KG.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Elanco
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Zoetis
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Merck & Co.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Bioveta, a.s.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Indian Immunologicals Ltd
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America cat vaccines market, by region, 2018-2030 (USD Million)
Table 3 North America cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 4 North America cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 5 North America cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 6 North America cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 7 North America cat vaccines market, by component, 2018-2030 (USD Million)
Table 8 U.S. cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 9 U.S. cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 10 U.S. cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 11 U.S. cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 12 U.S. cat vaccines market, by component, 2018-2030 (USD Million)
Table 13 Canada cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 14 Canada cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 15 Canada cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 16 Canada cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 17 Canada cat vaccines market, by component, 2018-2030 (USD Million)
Table 18 Europe cat vaccines market, by region, 2018-2030 (USD Million)
Table 19 Europe cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 20 Europe cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 21 Europe cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 22 Europe cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 23 Europe cat vaccines market, by component, 2018-2030 (USD Million)
Table 24 Germany cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 25 Germany cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 26 Germany cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 27 Germany cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 28 Germany cat vaccines market, by component, 2018-2030 (USD Million)
Table 29 UK cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 30 UK cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 31 UK cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 32 UK cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 33 UK cat vaccines market, by component, 2018-2030 (USD Million)
Table 34 France cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 35 France cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 36 France cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 37 France cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 38 France cat vaccines market, by component, 2018-2030 (USD Million)
Table 39 Italy cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 40 Italy cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 41 Italy cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 42 Italy cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 43 Italy cat vaccines market, by component, 2018-2030 (USD Million)
Table 44 Spain cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 45 Spain cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 46 Spain cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 47 Spain cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 48 Spain cat vaccines market, by component, 2018-2030 (USD Million)
Table 49 Denmark cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 50 Denmark cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 51 Denmark cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 52 Denmark cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 53 Denmark cat vaccines market, by component, 2018-2030 (USD Million)
Table 54 Sweden cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 55 Sweden cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 56 Sweden cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 57 Sweden cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 58 Sweden cat vaccines market, by component, 2018-2030 (USD Million)
Table 59 Norway cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 60 Norway cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 61 Norway cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 62 Norway cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 63 Norway cat vaccines market, by component, 2018-2030 (USD Million)
Table 64 Asia Pacific cat vaccines market, by region, 2018-2030 (USD Million)
Table 65 Asia Pacific cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 66 Asia Pacific cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 67 Asia Pacific cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 68 Asia Pacific cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 69 Asia Pacific cat vaccines market, by component, 2018-2030 (USD Million)
Table 70 China cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 71 China cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 72 China cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 73 China cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 74 China cat vaccines market, by component, 2018-2030 (USD Million)
Table 75 Japan cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 76 Japan cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 77 Japan cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 78 Japan cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 79 Japan cat vaccines market, by component, 2018-2030 (USD Million)
Table 80 India cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 81 India cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 82 India cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 83 India cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 84 India cat vaccines market, by component, 2018-2030 (USD Million)
Table 85 South Korea cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 86 South Korea cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 87 South Korea cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 88 South Korea cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 89 South Korea cat vaccines market, by component, 2018-2030 (USD Million)
Table 90 Australia cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 91 Australia cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 92 Australia cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 93 Australia cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 94 Australia cat vaccines market, by component, 2018-2030 (USD Million)
Table 95 Thailand cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 96 Thailand cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 97 Thailand cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 98 Thailand cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 99 Thailand cat vaccines market, by component, 2018-2030 (USD Million)
Table 100 Latin America cat vaccines market, by region, 2018-2030 (USD Million)
Table 101 Latin America cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 102 Latin America cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 103 Latin America cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 104 Latin America cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 105 Latin America cat vaccines market, by component, 2018-2030 (USD Million)
Table 106 Brazil cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 107 Brazil cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 108 Brazil cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 109 Brazil cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 110 Brazil cat vaccines market, by component, 2018-2030 (USD Million)
Table 111 Mexico cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 112 Mexico cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 113 Mexico cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 114 Mexico cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 115 Mexico cat vaccines market, by component, 2018-2030 (USD Million)
Table 116 Argentina cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 117 Argentina cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 118 Argentina cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 119 Argentina cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 120 Argentina cat vaccines market, by component, 2018-2030 (USD Million)
Table 121 MEA cat vaccines market, by region, 2018-2030 (USD Million)
Table 122 MEA cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 123 MEA cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 124 MEA cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 125 MEA cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 126 MEA cat vaccines market, by component, 2018-2030 (USD Million)
Table 127 South Africa cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 128 South Africa cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 129 South Africa cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 130 South Africa cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 131 South Africa cat vaccines market, by component, 2018-2030 (USD Million)
Table 132 Saudi Arabia cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 133 Saudi Arabia cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 134 Saudi Arabia cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 135 Saudi Arabia cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 136 Saudi Arabia cat vaccines market, by component, 2018-2030 (USD Million)
Table 137 UAE cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 138 UAE cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 139 UAE cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 140 UAE cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 141 UAE cat vaccines market, by component, 2018-2030 (USD Million)
Table 142 Kuwait cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 143 Kuwait cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 144 Kuwait cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 145 Kuwait cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 146 Kuwait cat vaccines market, by component, 2018-2030 (USD Million)
Table 2 North America cat vaccines market, by region, 2018-2030 (USD Million)
Table 3 North America cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 4 North America cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 5 North America cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 6 North America cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 7 North America cat vaccines market, by component, 2018-2030 (USD Million)
Table 8 U.S. cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 9 U.S. cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 10 U.S. cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 11 U.S. cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 12 U.S. cat vaccines market, by component, 2018-2030 (USD Million)
Table 13 Canada cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 14 Canada cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 15 Canada cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 16 Canada cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 17 Canada cat vaccines market, by component, 2018-2030 (USD Million)
Table 18 Europe cat vaccines market, by region, 2018-2030 (USD Million)
Table 19 Europe cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 20 Europe cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 21 Europe cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 22 Europe cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 23 Europe cat vaccines market, by component, 2018-2030 (USD Million)
Table 24 Germany cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 25 Germany cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 26 Germany cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 27 Germany cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 28 Germany cat vaccines market, by component, 2018-2030 (USD Million)
Table 29 UK cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 30 UK cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 31 UK cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 32 UK cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 33 UK cat vaccines market, by component, 2018-2030 (USD Million)
Table 34 France cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 35 France cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 36 France cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 37 France cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 38 France cat vaccines market, by component, 2018-2030 (USD Million)
Table 39 Italy cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 40 Italy cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 41 Italy cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 42 Italy cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 43 Italy cat vaccines market, by component, 2018-2030 (USD Million)
Table 44 Spain cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 45 Spain cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 46 Spain cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 47 Spain cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 48 Spain cat vaccines market, by component, 2018-2030 (USD Million)
Table 49 Denmark cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 50 Denmark cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 51 Denmark cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 52 Denmark cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 53 Denmark cat vaccines market, by component, 2018-2030 (USD Million)
Table 54 Sweden cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 55 Sweden cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 56 Sweden cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 57 Sweden cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 58 Sweden cat vaccines market, by component, 2018-2030 (USD Million)
Table 59 Norway cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 60 Norway cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 61 Norway cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 62 Norway cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 63 Norway cat vaccines market, by component, 2018-2030 (USD Million)
Table 64 Asia Pacific cat vaccines market, by region, 2018-2030 (USD Million)
Table 65 Asia Pacific cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 66 Asia Pacific cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 67 Asia Pacific cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 68 Asia Pacific cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 69 Asia Pacific cat vaccines market, by component, 2018-2030 (USD Million)
Table 70 China cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 71 China cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 72 China cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 73 China cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 74 China cat vaccines market, by component, 2018-2030 (USD Million)
Table 75 Japan cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 76 Japan cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 77 Japan cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 78 Japan cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 79 Japan cat vaccines market, by component, 2018-2030 (USD Million)
Table 80 India cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 81 India cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 82 India cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 83 India cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 84 India cat vaccines market, by component, 2018-2030 (USD Million)
Table 85 South Korea cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 86 South Korea cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 87 South Korea cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 88 South Korea cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 89 South Korea cat vaccines market, by component, 2018-2030 (USD Million)
Table 90 Australia cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 91 Australia cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 92 Australia cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 93 Australia cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 94 Australia cat vaccines market, by component, 2018-2030 (USD Million)
Table 95 Thailand cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 96 Thailand cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 97 Thailand cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 98 Thailand cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 99 Thailand cat vaccines market, by component, 2018-2030 (USD Million)
Table 100 Latin America cat vaccines market, by region, 2018-2030 (USD Million)
Table 101 Latin America cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 102 Latin America cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 103 Latin America cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 104 Latin America cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 105 Latin America cat vaccines market, by component, 2018-2030 (USD Million)
Table 106 Brazil cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 107 Brazil cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 108 Brazil cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 109 Brazil cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 110 Brazil cat vaccines market, by component, 2018-2030 (USD Million)
Table 111 Mexico cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 112 Mexico cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 113 Mexico cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 114 Mexico cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 115 Mexico cat vaccines market, by component, 2018-2030 (USD Million)
Table 116 Argentina cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 117 Argentina cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 118 Argentina cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 119 Argentina cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 120 Argentina cat vaccines market, by component, 2018-2030 (USD Million)
Table 121 MEA cat vaccines market, by region, 2018-2030 (USD Million)
Table 122 MEA cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 123 MEA cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 124 MEA cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 125 MEA cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 126 MEA cat vaccines market, by component, 2018-2030 (USD Million)
Table 127 South Africa cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 128 South Africa cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 129 South Africa cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 130 South Africa cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 131 South Africa cat vaccines market, by component, 2018-2030 (USD Million)
Table 132 Saudi Arabia cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 133 Saudi Arabia cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 134 Saudi Arabia cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 135 Saudi Arabia cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 136 Saudi Arabia cat vaccines market, by component, 2018-2030 (USD Million)
Table 137 UAE cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 138 UAE cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 139 UAE cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 140 UAE cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 141 UAE cat vaccines market, by component, 2018-2030 (USD Million)
Table 142 Kuwait cat vaccines market, by vaccine type, 2018-2030 (USD Million)
Table 143 Kuwait cat vaccines market, by disease type, 2018-2030 (USD Million)
Table 144 Kuwait cat vaccines market, by route of administration, 2018-2030 (USD Million)
Table 145 Kuwait cat vaccines market, by duration of immunity, 2018-2030 (USD Million)
Table 146 Kuwait cat vaccines market, by component, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Cat vaccines market: market outlook
Figure 9 Cat vaccines competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Cat vaccines market driver impact
Figure 14 Cat vaccines market restraint impact
Figure 15 Cat vaccines market: Vaccine type movement analysis
Figure 16 Cat vaccines market: Vaccine type outlook and key takeaways
Figure 17 Modified/Attenuated Live market estimates and forecast, 2018-2030
Figure 18 Inactivated (Killed) estimates and forecast, 2018-2030
Figure 19 Others estimates and forecast, 2018-2030
Figure 20 Cat vaccines market: Disease type movement analysis
Figure 21 Cat vaccines market: Disease type outlook and key takeaways
Figure 22 Feline leukemia market estimates and forecasts, 2018-2030
Figure 23 Feline panleukopenia market estimates and forecasts, 2018-2030
Figure 24 Feline respiratory diseases market estimates and forecasts, 2018-2030
Figure 25 Feline rabies diseases market estimates and forecasts, 2018-2030
Figure 26 Other diseases market estimates and forecasts, 2018-2030
Figure 27 Cat vaccines market: route of administration movement analysis
Figure 28 Cat vaccines market: route of administration outlook and key takeaways
Figure 29 Injectables market estimates and forecasts, 2018-2030
Figure 30 Intranasal market estimates and forecasts, 2018-2030
Figure 31 Oral market estimates and forecasts, 2018-2030
Figure 32 Cat vaccines market: duration of immunity movement analysis
Figure 33 Cat vaccines market: duration of immunity outlook and key takeaways
Figure 34 1 Year market estimates and forecasts, 2018-2030
Figure 35 3 Year market estimates and forecasts, 2018-2030
Figure 36 Others market estimates and forecasts, 2018-2030
Figure 37 Cat vaccines market: component movement analysis
Figure 38 Cat vaccines market: component outlook and key takeaways
Figure 39 Combined vaccines market estimates and forecasts, 2018-2030
Figure 40 Mono vaccines market estimates and forecasts, 2018-2030
Figure 41 Global cat vaccines market: Regional movement analysis
Figure 42 Global cat vaccines market: Regional outlook and key takeaways
Figure 43 Global cat vaccines market share and leading players
Figure 44 North America market share and leading players
Figure 45 Europe market share and leading players
Figure 46 Asia Pacific market share and leading players
Figure 47 Latin America market share and leading players
Figure 48 Middle East & Africa market share and leading players
Figure 49 North America: SWOT
Figure 50 Europe SWOT
Figure 51 Asia Pacific SWOT
Figure 52 Latin America SWOT
Figure 53 MEA SWOT
Figure 54 North America, by country
Figure 55 North America
Figure 56 North America market estimates and forecasts, 2018-2030
Figure 57 U.S.
Figure 58 U.S. market estimates and forecasts, 2018-2030
Figure 59 Canada
Figure 60 Canada market estimates and forecasts, 2018-2030
Figure 61 Europe
Figure 62 Europe market estimates and forecasts, 2018-2030
Figure 63 UK
Figure 64 UK market estimates and forecasts, 2018-2030
Figure 65 Germany
Figure 66 Germany market estimates and forecasts, 2018-2030
Figure 67 France
Figure 68 France market estimates and forecasts, 2018-2030
Figure 69 Italy
Figure 70 Italy market estimates and forecasts, 2018-2030
Figure 71 Spain
Figure 72 Spain market estimates and forecasts, 2018-2030
Figure 73 Denmark
Figure 74 Denmark market estimates and forecasts, 2018-2030
Figure 75 Sweden
Figure 76 Sweden market estimates and forecasts, 2018-2030
Figure 77 Norway
Figure 78 Norway market estimates and forecasts, 2018-2030
Figure 79 Asia Pacific
Figure 80 Asia Pacific market estimates and forecasts, 2018-2030
Figure 81 China
Figure 82 China market estimates and forecasts, 2018-2030
Figure 83 Japan
Figure 84 Japan market estimates and forecasts, 2018-2030
Figure 85 India
Figure 86 India market estimates and forecasts, 2018-2030
Figure 87 Thailand
Figure 88 Thailand market estimates and forecasts, 2018-2030
Figure 89 South Korea
Figure 90 South Korea market estimates and forecasts, 2018-2030
Figure 91 Australia
Figure 92 Australia market estimates and forecasts, 2018-2030
Figure 93 Latin America
Figure 94 Latin America market estimates and forecasts, 2018-2030
Figure 95 Brazil
Figure 96 Brazil market estimates and forecasts, 2018-2030
Figure 97 Mexico
Figure 98 Mexico market estimates and forecasts, 2018-2030
Figure 99 Argentina
Figure 100 Argentina market estimates and forecasts, 2018-2030
Figure 101 Middle East and Africa
Figure 102 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 103 South Africa
Figure 104 South Africa market estimates and forecasts, 2018-2030
Figure 105 Saudi Arabia
Figure 106 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 107 UAE
Figure 108 UAE market estimates and forecasts, 2018-2030
Figure 109 Kuwait
Figure 110 Kuwait market estimates and forecasts, 2018-2030
Figure 111 Market share of key market players - Cat vaccines market
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Cat vaccines market: market outlook
Figure 9 Cat vaccines competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Cat vaccines market driver impact
Figure 14 Cat vaccines market restraint impact
Figure 15 Cat vaccines market: Vaccine type movement analysis
Figure 16 Cat vaccines market: Vaccine type outlook and key takeaways
Figure 17 Modified/Attenuated Live market estimates and forecast, 2018-2030
Figure 18 Inactivated (Killed) estimates and forecast, 2018-2030
Figure 19 Others estimates and forecast, 2018-2030
Figure 20 Cat vaccines market: Disease type movement analysis
Figure 21 Cat vaccines market: Disease type outlook and key takeaways
Figure 22 Feline leukemia market estimates and forecasts, 2018-2030
Figure 23 Feline panleukopenia market estimates and forecasts, 2018-2030
Figure 24 Feline respiratory diseases market estimates and forecasts, 2018-2030
Figure 25 Feline rabies diseases market estimates and forecasts, 2018-2030
Figure 26 Other diseases market estimates and forecasts, 2018-2030
Figure 27 Cat vaccines market: route of administration movement analysis
Figure 28 Cat vaccines market: route of administration outlook and key takeaways
Figure 29 Injectables market estimates and forecasts, 2018-2030
Figure 30 Intranasal market estimates and forecasts, 2018-2030
Figure 31 Oral market estimates and forecasts, 2018-2030
Figure 32 Cat vaccines market: duration of immunity movement analysis
Figure 33 Cat vaccines market: duration of immunity outlook and key takeaways
Figure 34 1 Year market estimates and forecasts, 2018-2030
Figure 35 3 Year market estimates and forecasts, 2018-2030
Figure 36 Others market estimates and forecasts, 2018-2030
Figure 37 Cat vaccines market: component movement analysis
Figure 38 Cat vaccines market: component outlook and key takeaways
Figure 39 Combined vaccines market estimates and forecasts, 2018-2030
Figure 40 Mono vaccines market estimates and forecasts, 2018-2030
Figure 41 Global cat vaccines market: Regional movement analysis
Figure 42 Global cat vaccines market: Regional outlook and key takeaways
Figure 43 Global cat vaccines market share and leading players
Figure 44 North America market share and leading players
Figure 45 Europe market share and leading players
Figure 46 Asia Pacific market share and leading players
Figure 47 Latin America market share and leading players
Figure 48 Middle East & Africa market share and leading players
Figure 49 North America: SWOT
Figure 50 Europe SWOT
Figure 51 Asia Pacific SWOT
Figure 52 Latin America SWOT
Figure 53 MEA SWOT
Figure 54 North America, by country
Figure 55 North America
Figure 56 North America market estimates and forecasts, 2018-2030
Figure 57 U.S.
Figure 58 U.S. market estimates and forecasts, 2018-2030
Figure 59 Canada
Figure 60 Canada market estimates and forecasts, 2018-2030
Figure 61 Europe
Figure 62 Europe market estimates and forecasts, 2018-2030
Figure 63 UK
Figure 64 UK market estimates and forecasts, 2018-2030
Figure 65 Germany
Figure 66 Germany market estimates and forecasts, 2018-2030
Figure 67 France
Figure 68 France market estimates and forecasts, 2018-2030
Figure 69 Italy
Figure 70 Italy market estimates and forecasts, 2018-2030
Figure 71 Spain
Figure 72 Spain market estimates and forecasts, 2018-2030
Figure 73 Denmark
Figure 74 Denmark market estimates and forecasts, 2018-2030
Figure 75 Sweden
Figure 76 Sweden market estimates and forecasts, 2018-2030
Figure 77 Norway
Figure 78 Norway market estimates and forecasts, 2018-2030
Figure 79 Asia Pacific
Figure 80 Asia Pacific market estimates and forecasts, 2018-2030
Figure 81 China
Figure 82 China market estimates and forecasts, 2018-2030
Figure 83 Japan
Figure 84 Japan market estimates and forecasts, 2018-2030
Figure 85 India
Figure 86 India market estimates and forecasts, 2018-2030
Figure 87 Thailand
Figure 88 Thailand market estimates and forecasts, 2018-2030
Figure 89 South Korea
Figure 90 South Korea market estimates and forecasts, 2018-2030
Figure 91 Australia
Figure 92 Australia market estimates and forecasts, 2018-2030
Figure 93 Latin America
Figure 94 Latin America market estimates and forecasts, 2018-2030
Figure 95 Brazil
Figure 96 Brazil market estimates and forecasts, 2018-2030
Figure 97 Mexico
Figure 98 Mexico market estimates and forecasts, 2018-2030
Figure 99 Argentina
Figure 100 Argentina market estimates and forecasts, 2018-2030
Figure 101 Middle East and Africa
Figure 102 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 103 South Africa
Figure 104 South Africa market estimates and forecasts, 2018-2030
Figure 105 Saudi Arabia
Figure 106 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 107 UAE
Figure 108 UAE market estimates and forecasts, 2018-2030
Figure 109 Kuwait
Figure 110 Kuwait market estimates and forecasts, 2018-2030
Figure 111 Market share of key market players - Cat vaccines market
Companies Mentioned
- Virbac
- C.H. Boehringer Sohn AG & Co. KG.
- Elanco
- Zoetis
- Merck & Co.
- Bioveta, a.s.
- Indian Immunologicals Ltd
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.34 Billion |
| Forecasted Market Value ( USD | $ 2.5 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 7 |
